[Juvenile idiopathic arthritis. II. Treatment and prognosis].

Abstract

Immunosuppressants, including methotrexate and more recently anti-TNFalpha, have modified the prognosis of the most severe forms juvenile idiopathic arthritis. However, the therapeutic management is still challenging and adjuvant therapies, including physiotherapy, surgery, or even bisphosphonates and growth hormone, are still widely used to limit the negative impact of an extended general corticotherapy.

• Authors: Pierre Quartier, Anne-Marie Prieur
• Journal: La Revue du praticien (Rev Prat) Vol. 57 Issue 12 Pg. 1289-93 (Jun 30 2007) ISSN: 0035-2640 [Print] France
• Vernacular Title: Arthrites juvéniles idiopathiques. II. Traitement et pronostic.
• PMID: 17717939 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Immunosuppressive Agents
• Tumor Necrosis Factor-alpha

Topics

• Adolescent
• Arthritis, Juvenile (complications, therapy)
• Child
• Humans
• Immunosuppressive Agents (therapeutic use)
• Physical Therapy Modalities
• Prognosis
• Tumor Necrosis Factor-alpha (antagonists & inhibitors)